Article

Join the Conversation About Oncology Nurses

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Join us and our sister publication, Oncology Nursing News, for an #OncNurseConnect tweet chat on Wednesday, May 22 at 1:00 EST to discuss highlights from the conference. We want to hear about your wonderful stories with oncology nurses, as well as your patient experiences on new treatments and their side effects that were covered throughout the meeting.

To participate, follow @OncNursingNews, which will be tweeting out the questions. Once the question is asked, just join in and remember to use the #OncNurseConnect hashtag.

We hope to see you there!

Related Videos
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Related Content
Illustration of lungs.
January 14th 2025

FDA Grants Priority Review to Sunvozertinib for EGFR Exon20+ NSCLC

Alex Biese
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
An image of a patient and doctor holding hands.
January 14th 2025

The Pros and Cons of Seeking a Second Opinion In Cancer Treatment

Dr. Mohammad Jahanzeb
An expert explains the importance of getting a second opinion during a cancer journey.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of bladder.
January 13th 2025

Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer

Alex Biese
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Image of doctor and patient holding hands.
January 13th 2025

Hackensack University Medical Center Launches Educational Website for People with Kidney Cancer

John Theurer Cancer Center
Members of the Department of Urology at Hackensack University Medical Center have launched the Kidney Cancer Resource Center.